Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Why There's Limited Supply Of The Weight Loss Drug Zepbound
01:37pm, Wednesday, 03'rd Apr 2024
Zepound—an Eli Lilly-produced drug that has become a popular alternative to other weight loss drugs such as Wegovy and Ozempic—is facing a shortage in the U.S. of some of its doses because of the
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
01:33pm, Wednesday, 03'rd Apr 2024
Drugmakers spent big on ads for weight loss and diabetes drugs such as Wegovy and Ozempic. Meanwhile, the FDA approved the first AI diagnostic tool for sepsis.
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note
06:51pm, Tuesday, 02'nd Apr 2024
The latest trading day saw Eli Lilly (LLY) settling at $763.96, representing a +0.45% change from its previous close.
Biotech's Next Gold Rush: Weight-Loss Drugs
04:56pm, Tuesday, 02'nd Apr 2024
Biotech's next gold rush is weight-loss drugs. There is a dominance of NVO and LLY in this space for now, notes Rahul Jasuja.
5 Healthcare Stocks to Buy for 2024
04:30pm, Tuesday, 02'nd Apr 2024
What has been the top-performing stock so far of 2024? If you had said server installer Super Micro Computer (NASDAQ: SMCI ), that would be a great answer.
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
12:22pm, Tuesday, 02'nd Apr 2024
Four doses of Eli Lilly's diabetes drug Mounjaro would remain in tight supply through 2024 due to soaring demand, the U.S. Food and Drug Administration's website showed.
Eli Lilly's Ozempic Competitors Face Risks. Why the Stock Has More Upside.
08:51am, Tuesday, 02'nd Apr 2024
Citi analyst Andrew Baum raised his price target on Lilly stock to $895 from $675, citing increased sales expectations for a new drug.
Is It Too Late to Buy Eli Lilly Stock?
05:10am, Tuesday, 02'nd Apr 2024
Eli Lilly shares have climbed in the triple digits over the past year, and earnings have soared too. The company sells two of the world's most sought-after products right now: weight-loss drugs.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:06am, Monday, 01'st Apr 2024
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
11:15am, Sunday, 31'st Mar 2024
Eli Lilly's stock has seen significant growth due to the success of its obesity drug, "Zepbound," but its high valuation and upcoming competition make it less attractive. Amgen, with its obesity candi
Have $1,500? 2 Top Growth Stocks to Buy Right Now for 2024 and Beyond
09:45am, Sunday, 31'st Mar 2024
The pharmaceutical and e-commerce industries have proven to be resilient places to invest. Eli Lilly is riding a wave of sales from new blockbuster drugs on top of its flagship products.
Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data
02:10am, Sunday, 31'st Mar 2024
Eli Lilly and Novo Nordisk have created what Wall Street believes will be the biggest ever pharmaceutical market with its miraculous weight loss drugs. Novo Nordisk's Ozempic and Wegovy, as well as El
International Companies Drive Diabesity Innovation
09:59am, Friday, 29'th Mar 2024
International Companies Drive Diabesity Innovation
The 3 Best Biotech Stocks to Buy in Q2 2024
06:40am, Friday, 29'th Mar 2024
Biotech is an industry full of opportunity. It's also known as one of the riskiest sectors to invest in.
Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets
03:23am, Friday, 29'th Mar 2024
Eli Lilly's stock price rise continues unabated in 2023, backed by strong topline growth in 2023 and a sunny outlook for 2024. Its diabetes treatments look particularly encouraging, with Mounjaro's 11
